Gender: Female
Clinical Interest for Patients: I am interested in Pediatric and Perinatal HIV Infection, HIV Vaccines and Immune Responses to Infection.

Research Interests
I am studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. I develop immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and have chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. I am a frequently invited speaker at local, national, and international events.

Clinical Interests for Referring Providers: I am interested in Pediatric and Perinatal HIV Infection, HIV Vaccines and Immune Responses to Infection.

Research Interest for Referring Providers: Dr. McFarland is studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. Dr. McFarland develops immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and has chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. She is a frequently invited speaker at local, national, and international events.